Calendar Dermata Therapeutics, Inc.

Equities

DRMA

US2498453065

Market Closed - Nasdaq 02:00:00 27/04/2024 am IST 5-day change 1st Jan Change
0.3427 USD +0.76% Intraday chart for Dermata Therapeutics, Inc. +6.73% -43.82%

Chart calendar Dermata Therapeutics, Inc.

90cbcc426c677753cf741193948.mvWWr1eK6NkoElu5xws_PLfRCF74l6qQB18RTpxY5RE._bvE4ALbhpxjXhnIt190VO2hbh-B_pj8UwhSHOkv1UnAv8beEu2ys2BdPA~ccc3c8950e596947b3575d0005f70738

Upcoming events on Dermata Therapeutics, Inc.

07/05/2024 09:30 pm Annual General Meeting
13/05/2024 Q1 2024 Earnings Release (Projected)
23/09/2024 Q2 2024 Earnings Release (Projected)
07/11/2024 Q3 2024 Earnings Release (Projected)
31/03/2025 Q4 2024 Earnings Release (Projected)

Past events on Dermata Therapeutics, Inc.

04/04/2024 01:25 am Emerging Growth Conference
22/03/2024 01:35 am Q4 2023 Earnings Release
07/02/2024 11:05 pm Emerging Growth Conference
12/01/2024 10:30 pm Extraordinary Shareholders Meeting
10/11/2023 02:35 am Q3 2023 Earnings Release
11/09/2023 04:30 pm H.C. Wainwright Global Investment Conference
11/08/2023 01:45 am Q2 2023 Earnings Release
03/08/2023 09:30 pm Annual General Meeting
12/05/2023 01:35 am Q1 2023 Earnings Release
22/02/2023 02:35 am FY 2022 Earnings Release
08/02/2023 Extraordinary Shareholders Meeting
11/11/2022 03:50 am Q3 2022 Earnings Release
12/09/2022 04:30 pm H.C. Wainwright Global Investment Conference
01/09/2022 01:00 am Gilmartin Group Emerging Growth Conference
16/08/2022 01:35 am Interim 2022 Earnings Release
11/07/2022 09:30 pm Annual General Meeting
17/05/2022 01:35 am Q1 2022 Earnings Release
29/03/2022 12:30 am Maxim Group Virtual Growth Conference
28/03/2022 06:00 pm FY 2021 Earnings Release
10/01/2022 05:30 pm H.C. Wainwright BioConnect Conference

Annual results

Fiscal PeriodDecember 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBITDA
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
-7,86
-8,32
5.55%
-9,67
-10,5
7.55%
-8,04
-8,75
8.11%

-12,7

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-7,90
-8,93
11.54%
-9,61
-10,4
7.97%
-7,79
-8,55
8.81%

-15,0

Net income
Million USD
Released
Forecast
Spread
-10,5
-11,5
8.97%
-9,61
-10,4
7.97%
-7,79
-8,55
8.81%

-12,4

EPS
USD
Released
Forecast
Spread
-38,9
-50,9
23.58%
-13,9
-14,4
3.33%
-2,67
-4,22
36.73%

-1,38

Announcement Date28/03/2221/02/2321/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00


0,00

EBIT
Million USD
Released
Forecast
Spread
-2,55
-3,01
15.3%
-2,79
-3,34
16.58%
-2,73
-3,01
9.28%
-2,45
-2,71
9.57%
-1,71
-2,50
31.59%
-2,28
-2,11
-8%
-1,73
-2,21
21.49%
-1,81
-2,02
10.21%
-2,22
-2,93
24.24%

-2,51


-2,92


-3,30


-4,01

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-2,55
-3,59
28.79%
-2,79
-3,34
16.58%
-2,73
-3,01
9.28%
-2,42
-2,71
10.37%
-1,67
-2,50
33.27%
-2,24
-2,11
-6.22%
-1,70
-2,21
22.89%
-1,72
-2,00
13.87%
-2,13
-2,89
26.11%

-4,09


-3,88


-3,93


-3,12

Net income
Million USD
Released
Forecast
Spread
-2,55
-3,59
28.79%
-2,79
-3,34
16.58%
-2,73
-3,01
9.28%
-2,42
-2,71
10.37%
-1,67
-2,50
33.27%
-2,24
-2,11
-6.22%
-1,70
-2,21
22.89%
-1,72
-2,00
13.87%
-2,13
-2,89
26.11%

-2,40


-2,85


-3,20


-3,98

EPS
USD
Released
Forecast
Spread
-13,0
-6,72
-92.86%
-5,28
-6,40
17.5%
-3,84
-5,12
25%
-3,20
-3,52
9.09%
-1,92
-3,20
40%
-2,27
-2,65
14.34%
-0,63
-0,92
31.52%
-0,54
-0,63
14.29%
-0,21
-0,78
73.08%

-0,36


-0,42


-0,27


-0,33

Announcement Date28/03/2216/05/2215/08/2210/11/2221/02/2311/05/2310/08/2309/11/2321/03/24----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. DRMA Stock
  4. Calendar Dermata Therapeutics, Inc.